Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Transplant Immunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.TRIM.2005.10.002PMID 16431290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation

  2004cited by this paper
• The Pathophysiology of Acute Graft-versus-Host Disease

  2003cited by this paper
• Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects.

  2003cited by this paper
• Interleukin‐18

  2003cited by this paper
• Role of interleukin-18 in acute graft-vs-host disease.

  2003cited by this paper
• IL-18-independent cytotoxic T lymphocyte activation and IFN-gamma production during experimental acute graft-versus-host disease.

  2002cited by this paper
• Immunological reconstitution and immunoregulatory cells in hematopoietic stem cell transplantation

  2002cited by this paper
• Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease.

  2001cited by this paper
• Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis

  2001cited by this paper
• Interleukin-18 Binding Protein in Acute Graft versus Host Disease and Engraftment Following Allogeneic Peripheral Blood Stem Cell Transplants

  2001cited by this paper
• Soluble Interleukin-2 Receptor Concentration As a Biochemical Indicator for Acute Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation

  2000cited by this paper
• [Roles of Cytokines in Acute Graft-Versus-Host Disease]

  2000cited by this paper
• Th2 and Tc2 Cells in the Regulation of GVHD, GVL, and Graft Rejection: Considerations for the Allogeneic Transplantation Therapy of Leukemia and Lymphoma

  2000cited by this paper
• Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation.

  2000cited by this paper
• Elevated interleukin (IL)‐18 levels during acute graft‐versus‐host disease after allogeneic bone marrow transplantation

  2000cited by this paper
• Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-γ in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation

  2000cited by this paper
• Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantation as a marker for GVHD

  1998cited by this paper
• Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogeneic bone marrow transplantation

  1998cited by this paper
• Serum cytokine levels after HLA-identical bone marrow transplantation.

  1998cited by this paper
• Clinical relevance of serum soluble interleukin-2 receptor levels in acute and chronic graft-versus-host disease.

  1997cited by this paper
• The Immunopathophysiology of Acute Graft‐Versus‐Host‐Disease

  1996cited by this paper

• Inflammasomes: potential therapeutic targets in hematopoietic stem cell transplantation

  2024cites this paper
• A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin.

  2021cites this paper
• A new lateral flow assay to detect sIL-2R during T-cell mediated rejection after kidney transplantation.

  2021cites this paper
• Interleukin-18 and Hematopoietic Recovery after Allogeneic Stem Cell Transplantation

  2020cites this paper
• Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

  2020cites this paper
• Interleukin-18 and outcome after allogeneic stem cell transplantation: A retrospective cohort study

  2019cites this paper
• Cytokines in GVHD and GVL

  2019cites this paper
• Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading?

  2019cites this paper
• Effects on tumor immunity, liver, gut, lung and survival after cutaneous graft-versus-host disease regulated by photochemotherapy

  2018cites this paper
• Profiles of pro‐inflammatory cytokines in allogenic stem cell transplantation with post‐transplant cyclophosphamide

  2017cites this paper
• Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants—single centre pilot study

  2017cites this paper
• Diarrhea after allogeneic stem cell transplantation: beyond graft-versus-host disease.

  2017cites this paper
• Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients.

  2016cites this paper
• Soluble interleukin-2 receptor index predicts the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors

  2016cites this paper
• MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation

  2015cites this paper
• Complications of Allogeneic Stem Cell Transplantation

  2015cites this paper
• HHV-6A and HHV-6B in Recipients of Hematopoietic Cell Transplantation

  2014cites this paper
• Opportunities and challenges of proteomics in pediatric patients: Circulating biomarkers after hematopoietic stem cell transplantation as a successful example

  2014cites this paper
• Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.

  2014cites this paper
• Biomarkery choroby przeszczep-przeciw-gospodarzowi – współczesny stan wiedzy i nadzieje na przyszłość

  2013cites this paper
• Biomarkers for acute GVHD: can we predict the unpredictable?

  2013cites this paper
• Monitoring of TNFR1, IL-2Rα, HGF, CCL8, IL-8 and IL-12p70 following HSCT and their role as GVHD biomarkers in paediatric patients

  2013cites this paper
• A novel soluble form of Tim-3 associated with severe graft-versus-host disease.

  2013cites this paper
• Graft-versus-host disease biomarkers: omics and personalized medicine

  2013cites this paper
• Advances in hematopoietic stem cell transplantation for primary immunodeficiency

  2013cites this paper
• Proteomics in graft-versus-host disease and graft-versus-leukemia

  2013cites this paper
• Cytokines in Graft-versus-host Disease and Graft-versus-leukemia

  2013cites this paper
• Concentraciones de interleucina-2 en preeclámpticas y embarazadas normotensas sanas

  2012cites this paper
• Clinical applications for biomarkers of acute and chronic graft-versus-host disease.

  2012cites this paper
• Biomarkers for the detection of graft-versus-host disease in cancer patients after bone marrow transplantation

  2012cites this paper
• Potential biomarkers for early detection of acute graft‐versus‐host disease

  2012influential citation
• HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.

  2012cites this paper
• Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)?

  2012cites this paper
• Clinical Applications for Biomarkers of Acute and Chronic Graft vs. Host Disease

  2012cites this paper
• Discovery and validation of graft-versus-host disease biomarkers.

  2011cites this paper
• CONCENTRACIONES DE INTERLEUCINA-2 EN PACIENTES CON PREECLAMPSIA A TÉRMINO Y PRETÉRMINO

  2010cites this paper
• Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines.

  2010cites this paper
• Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality.

  2009cites this paper
• Procalcitonin and C-reactive protein serum levels after hematopoietic stem-cell transplant.

  2009cites this paper
• Plasma biomarkers in graft-versus-host disease: a new era?

  2009cites this paper
• A biomarker panel for acute graft-versus-host disease.

  2009cites this paper
• [Myeloablative radioimmunotherapy with 188Re-CD66mAb before stem cell transplantation. No increase of proinflammatory cytokine levels of TNF-alpha].

  2009cites this paper
• Plasma biomarkers in GVHD: a new era?

  2009cites this paper
• Myeloablative radioimmunotherapy with 188Re-CD66mAb before stem cell transplantation

  2008cites this paper
• Role Of Cytokines In The Immunopathogenesis Of Graft-versus-host Disease [papel Das Citocinas Na Imunopatogênese Da Doença Do Enxerto Contra O Hospedeiro]

  2008cites this paper
• The immunosuppressive effects of nicotine during human mixed lymphocyte reaction.

  2007cites this paper
• Effect of adenosine receptor subtypes stimulation on mixed lymphocyte reaction.

  2007cites this paper